PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
31259152-0	2019	Ursolic Acid Reverses the Chemoresistance of Breast Cancer Cells to Paclitaxel by Targeting MiRNA-149-5p/MyD88.	ursolic acid	0-12	myeloid differentiation primary response gene 88	Mus musculus	105-110	
31302461-0	2019	Ursolic acid exhibits anti-inflammatory effects through blocking TLR4-MyD88 pathway mediated by autophagy.	ursolic acid	0-12	myeloid differentiation primary response gene 88	Mus musculus	70-75	
31259152-14	2019	Meanwhile, the downregulation of MyD88 through the overexpression of miR-149-5p or UA treatment inhibited the activation of the Akt signaling pathway in 231/PTX cells.	ursolic acid	83-85	myeloid differentiation primary response gene 88	Mus musculus	33-38	
31259152-15	2019	Thus, our data indicate that UA can reverse PTX resistance by targeting the miRNA-149-5p/MyD88 axis in breast cancer cells.	ursolic acid	29-31	myeloid differentiation primary response gene 88	Mus musculus	89-94	
29735887-7	2018	Pre-treatment of UA also inhibited TLR4/MyD88 signaling activated by LPS.	ursolic acid	17-19	myeloid differentiation primary response gene 88	Mus musculus	40-45	
21496491-6	2011	Mechanistically, UA markedly inhibited LPS-induced IkappaBalpha phosphorylation and degradation, NF-kappaB p65 nuclear translocation and p38 activation in mouse brain, but did not affect the activation of TLR4, MyD88, ERK, JNK and Akt.	ursolic acid	17-19	myeloid differentiation primary response gene 88	Mus musculus	211-216	
25213465-5	2014	Ursolic acid not only inhibited the Alexa Fluor 488-conjugated LPS-mediated shift of macrophages but also reduced the intensity of fluorescent LPS bound to the macrophages transiently transfected with or without MyD88 siRNA.	ursolic acid	0-12	myeloid differentiation primary response gene 88	Mus musculus	212-217